Long-term Risk of Cancer Following Ileal Pouch-anal Anastomosis for Ulcerative Colitis
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Standard
Long-term Risk of Cancer Following Ileal Pouch-anal Anastomosis for Ulcerative Colitis. / Mark-Christensen, Anders; Erichsen, Rune; Brandsborg, Søren; Rosenberg, Jacob; Qvist, Niels; Thorlacius-Ussing, Ole; Hillingsø, Jens; Pachler, Jørn Helmut; Christiansen, Erica Gould; Laurberg, Søren.
I: Journal of Crohn's and Colitis, Bind 12, Nr. 1, 2018, s. 57-62.Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Long-term Risk of Cancer Following Ileal Pouch-anal Anastomosis for Ulcerative Colitis
AU - Mark-Christensen, Anders
AU - Erichsen, Rune
AU - Brandsborg, Søren
AU - Rosenberg, Jacob
AU - Qvist, Niels
AU - Thorlacius-Ussing, Ole
AU - Hillingsø, Jens
AU - Pachler, Jørn Helmut
AU - Christiansen, Erica Gould
AU - Laurberg, Søren
N1 - Copyright © 2017 European Crohn’s and Colitis Organisation (ECCO). Published by Oxford University Press. All rights reserved. For permissions, please email: journals.permissions@oup.com
PY - 2018
Y1 - 2018
N2 - Background: The overall risk of cancer following ileal pouch-anal anastomosis [IPAA] is unknown, and pouch cancer surveillance is controversial. We evaluated long-term risk of cancer in a national cohort of patients with ulcerative colitis and IPAA, with emphasis on pouch cancer.Methods: Data on incident cancers were extracted from the national Danish Cancer Registry. Incidence rates for all site-specific cancers were compared between patients with IPAA and a gender- and age-matched comparison cohort from the background population to obtain incidence rate ratios [IRRs].Results: A total of 1723 patients with IPAA, operated for ulcerative colitis in the period 1980-2010, were matched to 8615 individuals from the background population. During a median follow-up of 12.9 years (interquartile range [IQR] 7.7-19.6 years), two pouch cancers [0.12%] were found after 16 and 27 years, respectively. In the population comparison cohort, 38 intestinal cancers [0.45%] were found, of which 35 were colorectal. The risk of hepatobiliary cancer was higher for patients with IPAA {IRR = 13.0 (95% confidence interval [CI]: 3.1-76.1)}, and half of the affected patients had coexisting primary sclerosing cholangitis. The risk of cancer overall following IPAA was identical to that of the comparison cohort: IRR = 1.05 [0.84-1.31].Conclusions: Pouch cancer following IPAA is very rare, questioning the need for general, rather than selective, surveillance. The overall cancer risk is comparable to that of the background population, and the increased risk of hepatobiliary cancer is likely an effect of coexisting liver disease and not causally related to IPAA.
AB - Background: The overall risk of cancer following ileal pouch-anal anastomosis [IPAA] is unknown, and pouch cancer surveillance is controversial. We evaluated long-term risk of cancer in a national cohort of patients with ulcerative colitis and IPAA, with emphasis on pouch cancer.Methods: Data on incident cancers were extracted from the national Danish Cancer Registry. Incidence rates for all site-specific cancers were compared between patients with IPAA and a gender- and age-matched comparison cohort from the background population to obtain incidence rate ratios [IRRs].Results: A total of 1723 patients with IPAA, operated for ulcerative colitis in the period 1980-2010, were matched to 8615 individuals from the background population. During a median follow-up of 12.9 years (interquartile range [IQR] 7.7-19.6 years), two pouch cancers [0.12%] were found after 16 and 27 years, respectively. In the population comparison cohort, 38 intestinal cancers [0.45%] were found, of which 35 were colorectal. The risk of hepatobiliary cancer was higher for patients with IPAA {IRR = 13.0 (95% confidence interval [CI]: 3.1-76.1)}, and half of the affected patients had coexisting primary sclerosing cholangitis. The risk of cancer overall following IPAA was identical to that of the comparison cohort: IRR = 1.05 [0.84-1.31].Conclusions: Pouch cancer following IPAA is very rare, questioning the need for general, rather than selective, surveillance. The overall cancer risk is comparable to that of the background population, and the increased risk of hepatobiliary cancer is likely an effect of coexisting liver disease and not causally related to IPAA.
KW - Adult
KW - Biliary Tract Neoplasms/epidemiology
KW - Case-Control Studies
KW - Cholangitis, Sclerosing/complications
KW - Colitis, Ulcerative/complications
KW - Colonic Pouches/pathology
KW - Colorectal Neoplasms/epidemiology
KW - Denmark/epidemiology
KW - Female
KW - Follow-Up Studies
KW - Humans
KW - Incidence
KW - Liver Neoplasms/epidemiology
KW - Male
KW - Proctocolectomy, Restorative
KW - Registries
KW - Time Factors
KW - Young Adult
U2 - 10.1093/ecco-jcc/jjx112
DO - 10.1093/ecco-jcc/jjx112
M3 - Journal article
C2 - 28981638
VL - 12
SP - 57
EP - 62
JO - Journal of Crohn's and Colitis
JF - Journal of Crohn's and Colitis
SN - 1873-9946
IS - 1
ER -
ID: 215369561